• 제목/요약/키워드: E6

검색결과 21,657건 처리시간 0.042초

붉은서나물 지상부의 성분 (Constituents of Aerial Parts from Erechtites hieracifolia)

  • 이재훈;권학철;최상진;이원빈;방은정
    • 약학회지
    • /
    • 제45권4호
    • /
    • pp.339-346
    • /
    • 2001
  • A new oxygenated monoterpene (4) was isolated from the methanol extract of the aerial part of Erechtites hieracifolia together with six known components, a dimethylheptane (1), three ionone derivatives (2, 3 and 7) and two phenylpropanoids (5 and 6). Their structures were identified by means of physico-chemical and spectral data to be (2E, 5E)-6-hydroxy-2,6-dimethylhepta-2,4-dienal (1), 3(R)-hydroxy-5,6-epoxy-$\beta$-ionone (2), 3(R)-hydroxy-5,6-epoxy-7-ionol (3), (3E, 6E)-3,7-dimethylocta-3,5-dien-1,2,7-triol(4), 2-hydroxy-4-(2-propenyl)phenyl-$\beta$-D-glucopyranoside (5), 2-methoxy-4-(2-propenyl)phenyl -$\beta$-D-glucopyra-noside (6) and (6R, 9R)-3-oxo-$\beta$-ionol-$\alpha$-D -glucopyranoside (7).

  • PDF

핸드스프링 몸접어 앞공중돌기동작의 운동학적 분석 (The Kinematic Analysis of Handspring Salto Forward Piked)

  • 권오석
    • 한국운동역학회지
    • /
    • 제17권1호
    • /
    • pp.145-153
    • /
    • 2007
  • The purpose of this study is to compare and analyze the phase-by-phase elapsed time, the COG, the body joint angle changes and the angular velocities of each phase of Handspring Salto Forward Piked performed by 4 college gymnasts through 3D movement analysis program. 1. The average elapsed time for each phase was .13sec for Phase 1, .18sec for Phase 2, .4sec for Phase 3, and .3sec for Phase 5. The elapsed time for Phase 1 to Phase 3 handspring was .35sec on average and the elapsed time for Phase 4 to Phase 5 handspring salto forward piked was .7sec on average. And so it showed that the whole elapsed time was 1.44sec. 2. The average horizontal changes of COG were 93.2 cm at E1, 138. 5 cm at E2, 215.7 cm at E3, 369.2 cm at E4, 450.7 cm at E5, and 553.1 cm at E6. The average vertical changes of COG were 83.1 cm at E1, 71.3 cm at E2, 78.9 cm at E3, 93.7 cm at E4, 150.8 cm at E5, and 97.2 cm at E6. 3. The average shoulder joint angles at each phase were 131.6 deg at E1, 153.5 deg at E2, 135.4 deg at E3, 113.4 deg at E4, 39.6 deg at E5, and 67.5 deg at E6. And the average hip joint angles at each phase were 82.2 deg at E1, 60 deg at E2, 101.9 deg at E3, 161.2 deg at E4, 97.7 deg at E5, and 167 deg at E6. 4. The average shoulder joint angular velocities at each phase were 130.9deg/s E1, 73.1 deg/s at E2, -133.9 deg/s at E3, -194.4 deg/s at E4, 29.4 deg/s at E5, and -50.1 deg/s at E6. And the average hip joint angular velocities at each phase were -154.7 deg/s E1, -96.5 deg/s at E2, 495.9 deg/s at E3, 281.5 deg/s at E4, 90.3 deg/s at E5, and 181.7 deg/s at E6. The results shows that, as for the performance of handspring salto forward piked, it is important to move in short time and horizontally from the hop step to the point to place the hands on the floor and jump, and to stretch the hip joints as much as possible after the displacement of the hands and to keep the hip joints stretched and high in the vertical position at the takeoff. And it is also important to bend the shoulder joints and the hip joints fast and spin as much as possible after the takeoff, and to decrease the speed of spinning by bending he shoulder joints and the hip joints quickly after the highest point of COG and make a stable landing.

Analysis of Telomerase Activity by HPV E6/E7 Expression in SW13

  • 김영권
    • 대한의생명과학회지
    • /
    • 제12권4호
    • /
    • pp.399-403
    • /
    • 2006
  • Cervical cancer is one of the most prevalent cancers developed in women worldwide, and human papillomavirus (HPV) type 16 is the most common agent linked to human cerivical carcinoma. Viral oncogenes E6 and E7 are selectively ratined and expressed in carcinoma cells infected with human papillomavirus type 16 and cooperated with each other in immortalization and transformation of primary keratinocytes. Because of HPV oncogenesis mechanism was not completely solved, the more studies be required thoroughly. In the present study, to investigate the telomere independent role of telomerase in HPV oncogenesis, we constructed the E6 mutant, E7, E6/E7 and hTERT over-expressed stable cells with a telomerase negative cell line, SW13. Expressions of Inserted genes were measured by RT-PCR. E6, E7 and hTERT genes were well expressed in each cell lines comparing with the control groups. By analyzing the cell morphology under the microscope, hTERT clone size was a more smaller than the mock control but oncogene expressed clones were slightly lengthened the marginal region. In addition, hTERT cells has also, a tendency of brief dividing time compared to the mock control. To determine whether telomerase activity associated with a HPV oncogenesis by oncoprotein expression, we performed the PCR based TRAP assay and Northern blot analysis. In TRAP assay data, telomerase activities in hTERT and oncogene clones were more increased than the mock control. In addition, SW13/ E6/E7 cells appeared a extremely increased activity than any other clones. Induced TERT mRNA by E6/E7 wasn't, however, detected in Northern blotting. In conclusion, these findings suggest that telomerase activity closely associated the HPV oncogenesis and E6/E7 co-expression is a most important factor of telomerase activity.

  • PDF

C형 간염바이러스 코어 단백질에 의한 p53 활성화와 프로모터 과메틸화를 통한 E6AP 발현 억제 (Hepatitis C Virus Core Protein Activates p53 to Inhibit E6-associated Protein Expression via Promoter Hypermethylation)

  • 곽주리;장경립
    • 생명과학회지
    • /
    • 제28권9호
    • /
    • pp.1007-1015
    • /
    • 2018
  • E6AP (E6-associated protein)는 C형 간염바이러스(hepatitis C virus, HCV)의 코어 단백질 유비퀴틴화와 프로테오좀 분해를 유도하여 캡시드 조립을 저해함으로써 HCV 복제를 억제하는 것으로 알려져 있다. 반면에 HCV 코어 단백질은 숙주의 항바이러스 방어계에 대항하고 자신의 유비퀴틴-의존적 프로테아좀 분해를 막기 위하여 DNA 메틸화를 통하여 E6AP 발현을 저해하는 전략을 진화과정에서 획득하였다. 본 연구에서는 HCV 코어 단백질이 E6AP 발현을 저해하는 기전을 밝혀내고자 하였다. HCV 코어 단백질은 HepG2 세포에서 DNA 메틸화 효소들인 DNMT1, 3a 및 3b의 단백질 수준과 효소 활성을 증가시켜 프로모터 과메틸화를 통하여 E6AP 발현을 저해하였지만 p53를 발현하지 않는 Hep3B 세포에서는 이러한 효과들이 관찰되지 않았다. 흥미롭게도 Hep3B 세포에 p53만 과발현시키면 HCV 코어 단백질이 없더라도 DNMT가 활성화되고 프로모터 과메틸화를 통하여 E6AP 발현이 저해되었다. 또한 p53 녹다운 및 과발현 실험을 통하여 p53 활성화가 HCV 코어 단백질의 효과에 필수적임을 알 수 있었다. 이로 인하여 Hep3B 보다 HepG2 세포에서 낮은 수준의 유비퀴틴화된 HCV 코어 단백질이 검출되었다. 따라서 HCV 코어 단백질은 p53-의존적으로 자신의 유비퀴틴-매개성 프로테아좀 분해를 저해한다.

6${\beta}$-Bromopenicillanate로부터 6-(Carboxymethylthio) penicillanic Acid 유도체의 합성 (Synthesis of 6-(Carboxymethylthio) penicillanic Acid Derivatives from 6${\beta}$-Bromopenicillanates)

  • 최원식;이영행;이채호
    • 대한화학회지
    • /
    • 제35권5호
    • /
    • pp.575-579
    • /
    • 1991
  • 6${\beta}$-bromopenicillanic acid(4a)와 p-nitrobenzylbromide, 3-bromophthalide, chloromethylpivalate 및 1-chlorodiethylcarbonate의 반응으로 6${\beta}$-bromopenicillanates(4b~4e)을 합성하였으며, 6${\beta}$-bromopenicillanic acid(4a)와 그의 ester(4b~4e)를 thioglycolic acid와 친핵성 치환반응시켜 새로운 $\beta$-lactam계 화합물인 6-(carboxymethylthio)penicillanic acid(5a)와 그의 ester(5b~5e)를 얻었다.

  • PDF

Cytotoxic T Lymphocytes Elicited by Dendritic Cell-Targeted Delivery of Human Papillomavirus Type-16 E6/E7 Fusion Gene Exert Lethal Effects on CaSki Cells

  • Wu, Xiang-Mei;Liu, Xing;Jiao, Qing-Fang;Fu, Shao-Yue;Bu, You-Quan;Song, Fang-Zhou;Yi, Fa-Ping
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제15권6호
    • /
    • pp.2447-2451
    • /
    • 2014
  • Human papillomavirus (HPV) is the primary etiologic agent of cervical cancer. Consideration of safety and non human leukocyte antigen restriction, protein vaccine has become the most likely form of HPV therapeutic vaccine, although none have so far been reported as effective. Since tumor cells consistently express the two proteins E6 and E7, most therapeutic vaccines target one or both of them. In this study, we fabricated DC vaccines by transducing replication-defective recombinant adenoviruses expressing E6/E7 fusion gene of HPV-16, to investigate the lethal effects of specific cytotoxic T lymphocytes (CTL) against CaSki cells in vitro. Mouse immature dendritic cells (DC) were generated from bone marrow, and transfected with pAd-E6/E7 to prepare a DC vaccine and to induce specific CTL. The surface expression of CD40, CD68, MHC II and CD11c was assessed by flow cytometry (FCM), and the lethal effects of CTL against CaSki cells were determined by DAPI, FCM and CCK-8 methods. Immature mouse DC was successfully transfected by pAd-E6/E7 in vitro, and the transfecting efficiency was 40%-50%. A DC vaccine was successfully prepared and was used to induce specific CTL. Experimental results showed that the percentage of apoptosis and killing rate of CaSki cells were significantly increased by coculturing with the specific CTL (p <0.05). These results illustrated that a DC vaccine modified by HPV-16 E6/E7 gene can induce apoptosis of CaSki cells by inducing CTL, which may be used as a new strategy for biological treatment of cervical cancer.

적층가공 (3D 프린팅) Ti-6Al-4V합금의 국부부식 저항성 평가를 위한 임계국부부식온도와 임계국부부식전위 측정방법의 비교 (Measurement of Localized Corrosion Resistance in Additively Manufactured Ti-6Al-4V Alloys Using Electrochemical Critical Localized Corrosion Temperature (E-CLCT) versus Electrochemical Critical Localized Corrosion Potential (E-CLCP))

  • 서동일;이재봉
    • Corrosion Science and Technology
    • /
    • 제20권1호
    • /
    • pp.37-43
    • /
    • 2021
  • Additively manufactured (AM) Ti-6Al-4V alloys exhibit a dominant acicular martensite phase (α'), which is characterized by an unstable energy state and highly localized corrosion susceptibility. Electrochemical critical localized corrosion temperature (E-CLCT, ISO 22910: 2020) and electrochemical critical localized corrosion potential (E-CLCP, ISO AWI 4631: 2021) were measured to analyze the localized corrosion resistance of the AM Ti-6Al-4V alloy. Although E-CLCP was measured under mild corrosive conditions such as human body, the validity of evaluating localized corrosion resistance of AM titanium alloys was demonstrated by comparison with E-CLCT. However, the mechanisms of resistance to localized corrosion on the as-received and heat-treated AM Ti-6Al-4V alloys under E-CLCT and E-CLCP differ at various temperatures because of differences in properties under localized corrosion and repassivation. The E-CLCT is mainly measured for initiation of localized corrosion on the AM titanium alloys based on temperature, whereas the E-CLCP yields repassivation potential of re-generated passive films of AM titanium alloys after breaking down.

Farnesol의 입체선택적 합성 (Stereoselective Synthesis of Farnesol)

  • 신동수
    • 대한화학회지
    • /
    • 제36권4호
    • /
    • pp.579-583
    • /
    • 1992
  • 5-Bromo-2-methylpent-2-ene(2)을 출발물질로하여 farnesol인 (2E, 6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol(1)의 입체 선택적 합성을 수행하였다. 5-Bromo-2-methylpent-2-ene(2)을 요오드화시킨 후, 5-lithio-2,3-dihydrofuran과 반응시켜 5-(4-methylpent-3-enyl)-2,3-dihydrofuran(4)을 얻었다. Dihydrofuran 4를 MeMgI와 Ni(O)-촉매 짝지음 반응시켜 (3E)-4,8-dimethylnona-3,7-dien-1-ol(5)을 72%의 수율로 얻었다. 알릴알코올 5를 4단계로 거쳐 (5E)-6,10-dimethylundeca-5,9-dien-2-one(8)으로 변환시켰다. 화합물 8을 벤젠 용매하에서 dimethylmethoxycarbonylmethylphosponate와 반응시킨 다음, 에탄올 용매하에서 $NaBH_4$로 환원시켜서 (2E, 6E)-3,7,11-trimethyldodeca-2,6,10-tiren-1-ol(1)을 얻었다. Dihydrofuran 4와 MeMgI와의 Ni(O)-촉매 짝지음 반응이 본 연구의 farnsol(1)의 합성에서 중요한 단계이다.

  • PDF

백강잠(Bombysis corpus)으로부터 유용물질 분리 (A useful material isolation from the Bombycis corpus (Beauveria bassiana) growing of the silkworm, Bombyx mori L.)

  • 정이연;남성희;홍인표;유승헌;권학철;이강노
    • 한국잠사곤충학회지
    • /
    • 제45권1호
    • /
    • pp.25-30
    • /
    • 2003
  • 뇌신경세포주(PC12)에 백강잠의 분획물(조추출물)을 10 $\mu\textrm{g}$/ml 농도로 처리한 결과 헥산분획층과 부탄올분획층에서 뇌신경세포성장을 촉진하는 활성을 나타내어 헥산분획물로부터 화합물 4종(Fig.2: compound 1-4)과 부탄올분획물로부터 화합물 5종(Fig.2: compound 5-9)을 분리하여 각각의 화합물에 대하여도 검색한 결과 모두 뇌신경세포주(PC12)에 뇌신경세포 성장 촉진효과를 나타냈으며 특히 이들중 3종(4E, 6E, 2S, 3R)-2-N-Eicosanoy1-4,6-tetrade-casphingadienine,(4E, 6E, 2S, 3R)-2-N-Docosanoyl-4,6-tetradecasphingadienine, Urea)이 화합물은 NGF보다 우수한 활성을 나타냈다. 또한 헥산분획물로부터 분리한 4종의 스핑고신 유도체는 천연에서 처음 보고되는 물질이다. 이러한 결과로부터 백강잠 유래의 유효성분을 함유하는 추출물은 뇌졸중, 뇌허혈, 파킨슨, 노인성치매 및 헌팅턴질환을 포함하는 뇌질환 예방 및 치료를 위한 약학적 제제로 활용할 수 있을 것으로 기대된다.

소아 요로감염의 원인균주별 임상양상과 항생제 내성률 : 대장균과 비대장균의 비교 (Clinical Characteristics and Antibiotic Resistance of Urinary Tract Infections in Children: Escherichia. coli Versus Non-E. coli)

  • 배이영;이수영;정대철;강진한
    • Pediatric Infection and Vaccine
    • /
    • 제17권2호
    • /
    • pp.67-73
    • /
    • 2010
  • 목적:소아 UTI에서 non-E. coli UTI 의 빈도를 확인하고 원인균주별(E. coli vs. non-E. coli) 임상양상과 항생제 내성률을 비교하고자 하였다. 방 법: 2008년 9월부터 2009년 8월까지 UTI 입원 환아 중에서 원인균주가 배양 증명된 환아들을 대상으로 하였다. 인구학적 특징, 임상양상, 검사소견, 원인균주와 항생제 내성률을 전향적으로 조사하였다. 결과:전체 84명 중 E. coli UTI 은 63명(75.0%)이었고 non-E. coli UTI은 21명(25.0%)이었다. 성별 연령군에 따라서 non-E. coli의 분포는 차이를 보였다 : 6개월 미만 남아군, 10.5%; 6개월 이상 남아군, 50.0%; 6개월 미만 여아군, 43.7%; 6개월 이상 여아군, 25.0% (P =0.014). E. coli UTI군에 비해, non-E. coli UTI 군에는 입원 전 항생제를 치료받은 환아의 비율이 높았고(P=0.017), 혈뇨가 동반된 환아의 비율은 낮았다(P=0.014). E. coli 보다 non-E. coli는 cefazolin과 cefotaxime, imipenem, TMP/SMX, tetracycline에 대해 높은 내성률을 보였다(P<0.05). 결론:소아 UTI 치료과정에서, 증가 추세의 non-E. coli UTI 빈도와 성별 연령군별 원인균주의 차이, E. coli 보다 높은 non-E. coli의 항생제 내성률은 고려되어야 할 사항이다.